Insights

Life sciences in Alberta: State of the industry 2013

Learn more about the nature, health and productivity of life sciences in Alberta

This biennial report assesses the current landscape and what’s just ahead for the life sciences industry in Alberta. Download the report to learn more.

Life sciences is big business in Alberta. Deloitte’s third biennial report, Life sciences in Alberta: State of the industry 2013, assesses the current landscape and what’s just ahead for a growing industry. Key findings in this report include the following:

  • Medical technology & devices and health biotechnology & pharmaceuticals sectors account for over 60% of the life sciences industry in Alberta.
  • The life sciences industry contributed approximately 14,100 jobs in Alberta in 2012.
  • Government-facilitated programs, angel investors and corporate investors are the top sources of capital that respondents intend to access.
  • Aggregate R&D spending in 2012 reached its highest point (in dollars) since the survey began in 2006, with 60% of respondents planning to increase their spending in 2013.

To review and communicate the state of the life sciences industry in Alberta, we teamed up with our client, BioAlberta — a member-based not-for-profit representing the Alberta industry.

The future for Alberta’s life sciences industry

Despite some reductions to operations in the first half of 2013, Alberta’s life sciences industry has fared well overall and the future for Alberta’s life sciences industry remains bright. There are positive signs in the sector with expectations of strong research and development spending, cash on hand remaining steady and anticipated growth in employment.

Download the report to find out what Alberta’s life sciences industry is doing right; share it with your colleagues and use it as a tool to start conversations about thriving in a highly competitive environment.

 
Did you find this useful?